Listen: An Intersectional Look at Anal Cancer and HIV
07/28/22
Listen to an indepth conversation between the ANCHOR Study's Protocol Chair and Professor of Medicine at UCSF, Dr. Joel Palefsky, and the Director
News
Listen: Anal Cancer - It’s Time to Get Our Butts in Gear!
07/28/22
Hear a key conversation between ANCHOR Study investigator, Dr. Jessica Korman, and The BodyPro's, Miles Helfand, about how the ANCHOR Study is
NEJM: Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer
06/16/22
The incidence of anal cancer is substantially higher among persons living with the human immunodeficiency virus (HIV) than in the general
POZ: Screening and Early Treatment Reduce Anal Cancer in People With HIV
06/16/22
Prompt detection and treatment of precancerous lesions cut the likelihood of developing anal cancer by more than half.
WSJ: Study Finds Benefits of Active Screening, Treatment for Precursors of Anal Cancer
06/15/22
Subjects with HIV who had precancerous lesions and got proactive treatment had a 57% lower rate of progressing to cancer.
Scientific leaders signal major breakthroughs in elimination of cervical and anal cancers
03/04/22
HPV (human papillomavirus) is associated with 630,000 cancer diagnoses around the world. Almost all cases of cervical and anal cancers are caused
Ablating High-Grade Anal Lesions Thwarts Progression to Cancer
02/17/22
A protocol in which high-grade squamous intraepithelial lesions (HSIL) of the anal canal were immediately treated was more effective for
Screening and early treatment reduce anal cancer risk by 57% in people living with HIV
02/17/22
Screening for precancerous anal cell changes and treating them early lowers the risk of progression to anal cancer in people living with HIV,
Screening and Early Treatment Cuts Anal Cancer Risk
02/17/22
Prompt treatment of precancerous lesions reduced the likelihood of developing anal cancer by 57%.
Treating precancerous lesions reduces anal cancer risk in people with HIV
02/16/22
Treating high-grade squamous intraepithelial lesions — primarily with office-based electrocautery — led to an almost 60% reduction in anal cancer